FOUNTAIN LIFE OMIC, LLC – Trademark Portfolio
Entity Type: 16
FOUNTAIN LIFE OMIC, LLC owns a portfolio of 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as LIFEAPPS, LIFE ASCENT, and LIFE EXTEND. Of these, 4 are registered. The portfolio spans 3 Nice Classification classes, led by Class 42 (Computer & Scientific) and Class 9 (Computers & Electronics). Headquartered in WILMINGTON, DE.
251 LITTLE FALLS DRIVE
WILMINGTON, DE 19808
Showing of trademarks Trademarks
Trademark Classifications
FOUNTAIN LIFE OMIC, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does FOUNTAIN LIFE OMIC, LLC have?
FOUNTAIN LIFE OMIC, LLC has 7 U.S. trademarks filed with the USPTO. Of these, 4 registered, 3 cancelled.
What trademark classes does FOUNTAIN LIFE OMIC, LLC file in?
FOUNTAIN LIFE OMIC, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are FOUNTAIN LIFE OMIC, LLC's most well-known trademarks?
FOUNTAIN LIFE OMIC, LLC's registered trademark portfolio includes well-known marks such as LIFEAPPS, LIFE ASCENT, and LIFE EXTEND. These are among 4 currently registered trademarks in the portfolio.
What is FOUNTAIN LIFE OMIC, LLC's trademark registration success rate?
FOUNTAIN LIFE OMIC, LLC has a 57% trademark registration rate, with 4 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.